Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Genelux Corporation (GNLX)
US NASDAQ Healthcare Biotechnology
Address
2625 Townsgate Road 91361
Westlake Village, CA, US
Westlake Village, CA, US
CEO
Thomas D. Zindrick
Website
genelux.com
IPO
2023-01-26
CIK 1231457 ISIN US36870H1032
Description
Genelux Corporation is a clinical-stage biopharmaceutical company focused on pioneering advanced oncolytic viral immunotherapies for patients confronting aggressive and/or hard-to-treat solid tumor malignancies. Its leading experimental drug, Olvi-Vec, is a proprietary, engineered vaccinia virus strain being developed to address ovarian cancer and non-small cell lung cancer. The company is also advancing V2ACT Immunotherapy for pancreatic cancer, alongside V-VET1 for the treatment of both hematologic and solid cancers. Founded in 2001, Genelux maintains its headquarters in Westlake Village, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
190.9K
Beta
0.55
Float Shares
30.65M
Free Float %
81.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.75% | -0.34% | +14.17% | +16.47% | -51.10% | -33.49% | +4.32% | -88.63% | -52.85% | -52.85% | -52.85% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (3 ratings, all time)
Buy
Price Targets & DCF
Current price
2.78
Low
16.00
+475.5%
Consensus
17.33
+523.4%
Median
16.00
+475.5%
High
20.00
+619.4%
DCF (Unlevered)
0.10
-96.5%
DCF (Levered)
0.10
-96.5%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 3 |
17.33
|
| All Time | 3 |
17.33
|
Quality scores
Altman Z-Score
-8.44
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+0.0%
-
EPS growth Biotechnology: +29.7%+9.5% Q1'26: -4.8% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-428,250.0%
-
EBIT margin Biotechnology: +0.0%-415,175.0%
-
ROIC Biotechnology: -16.1%— Q1'26: +4,219.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+18.2% Q1'26: -6.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.05× Q1'26: -0.07× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 5 Rev. Ana. 4 EPS Ana. |
Dec 2029 2 Rev. Ana. 2 EPS Ana. |
Dec 2030 2 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
11.07M
est: 11.00M (+0.6%)
|
170.0K
est: 8.0K (+2,025.0%)
|
8.0K
est: 4.8K (+66.7%)
|
8.0K
est: 8.0K (+0.0%)
|
2.65M
2.65M – 2.65M
+33,022.5% YoY
|
12.22M
12.22M – 12.22M
+361.1% YoY
|
87.71M
87.71M – 87.71M
+617.8% YoY
|
188.14M
188.14M – 188.14M
+114.5% YoY
|
296.18M
296.18M – 296.18M
+57.4% YoY
|
| EBITDA |
-1.73M
est: -344.1K (-403.1%)
|
-26.46M
est: -3.5K (-766,769.6%)
|
-28.97M
est: -2.1K (-1,399,223.7%)
|
-32.64M
est: -3.5K (-945,987.0%)
|
-1.14M
-1.14M – -1.14M
-33,024.8% YoY
|
-5.27M
-5.27M – -5.27M
-361.1% YoY
|
-37.83M
-37.83M – -37.83M
-617.8% YoY
|
-81.14M
-81.14M – -81.14M
-114.5% YoY
|
-127.74M
-127.74M – -127.74M
-57.4% YoY
|
| EBIT |
-2.70M
est: -536.5K (-403.1%)
|
-27.48M
est: -3.6K (-765,220.3%)
|
-29.87M
est: -2.2K (-1,386,576.0%)
|
-33.21M
est: -3.6K (-925,081.1%)
|
-1.19M
-1.19M – -1.19M
-33,024.1% YoY
|
-5.48M
-5.48M – -5.48M
-361.1% YoY
|
-39.36M
-39.36M – -39.36M
-617.8% YoY
|
-84.43M
-84.43M – -84.43M
-114.5% YoY
|
-132.92M
-132.92M – -132.92M
-57.4% YoY
|
| Net Income |
-5.21M
est: -8.81M (+40.9%)
|
-28.30M
est: -35.99M (+21.4%)
|
-29.87M
est: -32.46M (+8.0%)
|
-32.15M
est: -31.48M (-2.1%)
|
-30.18M
-32.21M – -28.14M
+4.1% YoY
|
-27.42M
-27.42M – -27.42M
+9.1% YoY
|
-4.62M
-36.80M – 23.79M
+83.2% YoY
|
26.40M
26.40M – 26.40M
+671.7% YoY
|
56.60M
56.60M – 56.60M
+114.4% YoY
|
| SGA |
5.00M
est: 3.65B (-99.9%)
|
11.57M
est: 5.33M (+117.2%)
|
12.71M
est: 3.20M (+297.6%)
|
13.37M
est: 5.33M (+151.0%)
|
1.76B
1.76B – 1.76B
+33,022.5% YoY
|
8.14B
8.14B – 8.14B
+361.1% YoY
|
58.40B
58.40B – 58.40B
+617.8% YoY
|
125.27B
125.27B – 125.27B
+114.5% YoY
|
197.20B
197.20B – 197.20B
+57.4% YoY
|
| EPS |
-0.21
est: -0.28 (+25.0%)
|
-1.16
est: -0.97 (-19.8%)
|
-0.95
est: -0.88 (-8.2%)
|
-0.86
est: -0.85 (-1.6%)
|
-0.81
-0.87 – -0.76
+4.1% YoY
|
-0.74
-0.74 – -0.74
+9.1% YoY
|
-0.13
-0.99 – 0.64
+82.0% YoY
|
0.71
0.71 – 0.71
+635.8% YoY
|
1.52
1.52 – 1.52
+114.4% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-26.83M
OE per share TTM
-0.68
Owner's Yield
-21.47%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
175.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
16
Total invested
7.25M
Insider transactions (90d)
0
Beneficial owners (>5%)
3
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Aladar Szalay | 4.19M | 15.70% | 4.18M | 5.0K | 4.18M | 5.0K | IN | United States | 2024-02-02 | ↗ |
| 2 | Highbridge Capital Management, LLC | 2.50M | 6.80% | — | 2.50M | — | — | IA, OO | State of Delaware | 2024-10-25 | ↗ |
| 3 | Billy James Parrott | 2.33M | 8.70% | 2.33M | — | 2.33M | — | IN | United States America | 2023-06-20 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
16
-61 vs prev Q
New positions
1
Closed positions
61
Increased
5
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 41.0K +41.0K (+100.0%) | 178.58M +178.6M (+100.0%) | 0.11% +0.108 pp | 0.14% +0.140 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 2 | WOODWARD DIVERSIFIED CAPITAL, LLC | 1.93M +88.6K (+4.8%) | 8.43M +681.4K (+8.8%) | 5.10% +0.241 pp | 3.86% +0.252 pp | USD8.98 -51.4% | 10 qtrs — |
| 3 | VANGUARD GROUP INC | 1.55M +132.1K (+9.3%) | 6.76M +802.9K (+13.5%) | 4.09% +0.354 pp | 0.00% +0.000 pp | USD15.50 -71.9% | 12 qtrs — |
| 4 | BLEICHROEDER LP | 714.0K +— (+0.0%) | 3.11M +114.2K (+3.8%) | 1.88% +0.003 pp | 0.55% -0.037 pp | USD2.70 +61.5% | 4 qtrs — |
| 5 | BLACKROCK, INC. | 385.3K +5.4K (+1.4%) | 1.68M +84.4K (+5.3%) | 1.02% +0.016 pp | 0.00% +0.000 pp | USD2.66 +63.9% | 6 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 381.4K +27.6K (+7.8%) | 1.66M +177.4K (+11.9%) | 1.01% +0.074 pp | 0.00% +0.000 pp | USD15.00 -70.9% | 12 qtrs — |
| 7 | BANK OF AMERICA CORP /DE/ | 336.0K +12.5K (+3.9%) | 1.47M +106.4K (+7.8%) | 0.89% +0.034 pp | 0.00% +0.000 pp | USD3.47 +25.6% | 11 qtrs — |
| 8 | FLPUTNAM INVESTMENT MANAGEMENT CO | 303.3K +3.0K (+1.0%) | 1.32M +61.2K (+4.9%) | 0.80% +0.009 pp | 0.02% +0.000 pp | USD4.04 +7.9% | 3 qtrs — |
| 9 | ALYESKA INVESTMENT GROUP, L.P. | 285.0K +— (+0.0%) | 1.24M +45.6K (+3.8%) | 0.75% +0.001 pp | 0.00% 0.000 pp | USD2.70 +61.5% | 4 qtrs — |
| 10 | GLOBAL RETIREMENT PARTNERS, LLC | 217.1K -11.6K (-5.1%) | 946.5K -13.9K (-1.4%) | 0.57% -0.030 pp | 0.02% -0.005 pp | USD2.87 +51.9% | 3 qtrs — |
| 11 | GOLDMAN SACHS GROUP INC | 183.8K +150.5K (+451.2%) | 801.4K +661.4K (+472.2%) | 0.49% +0.397 pp | 0.00% +0.000 pp | USD4.21 +3.6% | 4 qtrs — |
| 12 | PROVIDENT WEALTH MANAGEMENT, LLC | 155.7K +— (+0.0%) | 678.7K +24.9K (+3.8%) | 0.41% +0.001 pp | 0.20% +0.003 pp | USD24.25 -82.0% | 10 qtrs — |
| 13 | STATE STREET CORP | 145.9K +27.2K (+22.9%) | 635.9K +137.6K (+27.6%) | 0.38% +0.072 pp | 0.00% +0.000 pp | USD11.70 -62.7% | 12 qtrs — |
| 14 | NORTHERN TRUST CORP | 142.8K +11.5K (+8.8%) | 622.8K +71.3K (+12.9%) | 0.38% +0.031 pp | 0.00% +0.000 pp | USD11.04 -60.5% | 12 qtrs — |
| 15 | MARSHALL WACE, LLP | 139.1K +105.4K (+312.3%) | 606.7K +465.0K (+328.0%) | 0.37% +0.278 pp | 0.00% +0.000 pp | USD4.01 +8.7% | 8 qtrs — |
| 16 | LPL FINANCIAL LLC | 134.4K +24.6K (+22.4%) | 585.8K +124.7K (+27.1%) | 0.35% +0.065 pp | 0.00% +0.000 pp | USD8.05 -45.8% | 10 qtrs — |
| 17 | 683 CAPITAL MANAGEMENT, LLC | 131.1K +131.1K (+100.0%) | 571.5K +571.5K (+100.0%) | 0.35% +0.346 pp | 0.02% +0.025 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 18 | LIFESTEPS FINANCIAL, INC. | 118.1K +12.9K (+12.3%) | 514.8K +73.1K (+16.5%) | 0.31% +0.034 pp | 0.33% +0.046 pp | USD10.06 -56.7% | 11 qtrs — |
| 19 | ADVISOR GROUP HOLDINGS, INC. | 110.0K -2.5K (-2.2%) | 479.5K +7.5K (+1.6%) | 0.29% -0.006 pp | 0.00% +0.000 pp | USD2.96 +47.3% | 12 qtrs — |
| 20 | MILLENNIUM MANAGEMENT LLC | 104.4K +104.4K (+100.0%) | 455.2K +455.2K (+100.0%) | 0.28% +0.276 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 9 qtrs — |
| 21 | QUBE RESEARCH & TECHNOLOGIES LTD | 92.8K +55.6K (+149.3%) | 404.6K +248.2K (+158.8%) | 0.24% +0.147 pp | 0.00% +0.000 pp | USD4.00 +9.0% | 7 qtrs — |
| 22 | MORGAN STANLEY | 92.2K +31.5K (+52.0%) | 401.9K +147.2K (+57.8%) | 0.24% +0.084 pp | 0.00% +0.000 pp | USD6.14 -29.0% | 12 qtrs — |
| 23 | BARCLAYS PLC | 82.6K +82.6K (+100.0%) | 360.2K +360.2K (+100.0%) | 0.22% +0.218 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 24 | AMG NATIONAL TRUST BANK | 75.4K +— (+0.0%) | 328.5K +12.1K (+3.8%) | 0.20% +0.000 pp | 0.01% +0.000 pp | USD16.97 -74.3% | 10 qtrs — |
| 25 | JANE STREET GROUP, LLC | 71.7K +71.7K (+100.0%) | 312.8K +312.8K (+100.0%) | 0.19% +0.189 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 4 qtrs — |
| 26 | FALCON WEALTH PLANNING | 63.2K +41.2K (+187.2%) | 275.5K +183.1K (+198.1%) | 0.17% +0.109 pp | 0.02% +0.015 pp | USD7.62 -42.8% | 10 qtrs — |
| 27 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 55.0K +55.0K (+100.0%) | 239.8K +239.8K (+100.0%) | 0.15% +0.145 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 3 qtrs — |
| 28 | OMERS ADMINISTRATION CORP | 54.8K +54.8K (+100.0%) | 238.9K +238.9K (+100.0%) | 0.14% +0.145 pp | 0.00% +0.002 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 29 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 54.6K +54.6K (+100.0%) | 238.2K +238.2K (+100.0%) | 0.14% +0.144 pp | 0.00% +0.002 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 30 | XTX TOPCO LTD | 51.0K +51.0K (+100.0%) | 222.5K +222.5K (+100.0%) | 0.13% +0.135 pp | 0.01% +0.006 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 31 | UBS GROUP AG | 47.4K +19.6K (+70.5%) | 206.5K +89.8K (+77.0%) | 0.13% +0.052 pp | 0.00% +0.000 pp | USD4.93 -11.6% | 12 qtrs — |
| 32 | CREATIVE PLANNING | 43.8K -2.3K (-5.0%) | 191.0K -2.7K (-1.4%) | 0.12% -0.006 pp | 0.00% +0.000 pp | USD2.46 +77.2% | 5 qtrs — |
| 33 | POINT72 ASSET MANAGEMENT, L.P. | 39.6K +39.6K (+100.0%) | 172.5K +172.5K (+100.0%) | 0.10% +0.104 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 34 | HUDSON BAY CAPITAL MANAGEMENT LP | 37.7K +37.7K (+100.0%) | 164.5K +164.5K (+100.0%) | 0.10% +0.100 pp | 0.00% +0.001 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 35 | ONE CAPITAL MANAGEMENT, LLC | 30.9K +— (+0.0%) | 134.6K +4.9K (+3.8%) | 0.08% +0.000 pp | 0.00% 0.000 pp | USD10.77 -59.5% | 10 qtrs — |
| 36 | RAYMOND JAMES FINANCIAL INC | 30.8K +— (+0.0%) | 134.1K +4.9K (+3.8%) | 0.08% +0.000 pp | 0.00% +0.000 pp | USD2.63 +65.8% | 5 qtrs — |
| 37 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 37.0K +37.0K (+100.0%) | 125.4K +125.4K (+100.0%) | 0.10% +0.098 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 38 | MAI CAPITAL MANAGEMENT | 25.9K -6.1K (-19.1%) | 112.8K -21.5K (-16.0%) | 0.07% -0.016 pp | 0.00% 0.000 pp | USD2.87 +51.9% | 5 qtrs — |
| 39 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 25.0K +— (+0.0%) | 109.0K +4.0K (+3.8%) | 0.07% +0.000 pp | 0.00% +0.000 pp | USD2.70 +61.5% | 4 qtrs — |
| 40 | KWB WEALTH | 23.3K +— (+0.0%) | 101.7K +34.8K (+51.9%) | 0.06% +0.000 pp | 0.01% +0.002 pp | USD14.01 -68.9% | 9 qtrs — |
| 41 | RENAISSANCE TECHNOLOGIES LLC | 23.1K -39.8K (-63.3%) | 100.7K -163.5K (-61.9%) | 0.06% -0.105 pp | 0.00% 0.000 pp | USD3.94 +10.7% | 8 qtrs — |
| 42 | LIGHTHOUSE INVESTMENT PARTNERS, LLC | 22.6K +22.6K (+100.0%) | 98.4K +98.4K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.003 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 43 | D.A. DAVIDSON & CO. | 21.8K +— (+0.0%) | 95.0K +3.5K (+3.8%) | 0.06% +0.000 pp | 0.00% +0.000 pp | USD2.36 +84.7% | 5 qtrs — |
| 44 | BALYASNY ASSET MANAGEMENT L.P. | 21.5K +21.5K (+100.0%) | 93.6K +93.6K (+100.0%) | 0.06% +0.057 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 45 | APOLLON WEALTH MANAGEMENT, LLC | 18.8K +— (+0.0%) | 81.9K +3.0K (+3.8%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD11.03 -60.5% | 9 qtrs — |
| 46 | 5T WEALTH, LLC | 18.0K -6.1K (-25.3%) | 78.5K -22.7K (-22.5%) | 0.05% -0.016 pp | 0.03% -0.013 pp | USD3.08 +41.6% | 4 qtrs — |
| 47 | COMMONWEALTH EQUITY SERVICES, LLC | 17.1K +— (+0.0%) | 74.5K +2.5K (+3.4%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD2.20 +98.2% | 7 qtrs — |
| 48 | LIBERTY WEALTH MANAGEMENT LLC | 16.5K +— (+0.0%) | 72.1K +2.6K (+3.8%) | 0.04% +0.000 pp | 0.01% -0.001 pp | USD2.70 +61.5% | 4 qtrs — |
| 49 | BROKERS INTERNATIONAL FINANCIAL SERVICES, LLC. | 15.1K +— (+0.0%) | 65.6K +2.4K (+3.8%) | 0.04% +0.000 pp | 0.00% -0.001 pp | USD4.20 +3.8% | 4 qtrs — |
| 50 | CITIGROUP INC | 14.9K +14.9K (+1,494,400.0%) | 65.2K +65.2K (+1,628,900.0%) | 0.04% +0.039 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 2 qtrs — |
| 51 | STRATOS WEALTH PARTNERS, LTD. | 12.7K +— (+0.0%) | 55.6K +2.0K (+3.8%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD2.37 +84.0% | 6 qtrs — |
| 52 | UNITED BANK | 12.1K +— (+0.0%) | 52.6K +1.9K (+3.8%) | 0.03% +0.000 pp | 0.01% +0.001 pp | USD2.87 +51.9% | 3 qtrs — |
| 53 | SQUAREPOINT OPS LLC | 11.9K +11.9K (+100.0%) | 51.7K +51.7K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 7 qtrs — |
| 54 | PRIVATE MANAGEMENT GROUP INC | 11.3K +— (+0.0%) | 49.4K +1.8K (+3.8%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD2.87 +51.9% | 3 qtrs — |
| 55 | JEFFERIES FINANCIAL GROUP INC. | 10.9K +10.9K (+100.0%) | 47.7K +47.7K (+100.0%) | 0.03% +0.029 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 56 | STEEL PEAK WEALTH MANAGEMENT LLC | 10.9K +— (+0.0%) | 47.5K +1.7K (+3.8%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD24.49 -82.2% | 10 qtrs — |
| 57 | CENTAURUS FINANCIAL, INC. | 10.0K +— (+0.0%) | 44.0K +2.0K (+4.8%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD2.36 +84.7% | 5 qtrs — |
| 58 | PLANCORP, LLC | 10.0K +— (+0.0%) | 43.6K +1.6K (+3.8%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD5.24 -16.8% | 8 qtrs — |
| 59 | RONALD BLUE TRUST, INC. | 9.5K -692.0 (-6.8%) | 41.3K -1.4K (-3.3%) | 0.03% -0.002 pp | 0.00% +0.000 pp | USD13.13 -66.8% | 9 qtrs — |
| 60 | BNP PARIBAS ARBITRAGE, SNC | 7.8K +3.4K (+76.1%) | 34.2K +15.5K (+82.9%) | 0.02% +0.009 pp | 0.00% +0.000 pp | USD4.20 +3.8% | 5 qtrs — |
| 61 | WHITTIER TRUST CO OF NEVADA INC | 7.1K +— (+0.0%) | 24.2K -7.6K (-23.8%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD14.01 -68.9% | 9 qtrs — |
| 62 | WELLS FARGO & COMPANY/MN | 4.5K -5.0 (-0.1%) | 19.6K +697.0 (+3.7%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD23.10 -81.1% | 12 qtrs — |
| 63 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.9K +3.4K (+724.8%) | 16.9K +15.0K (+756.4%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD4.34 +0.5% | 2 qtrs — |
| 64 | BROWN BROTHERS HARRIMAN & CO | 1.4K +— (+0.0%) | 5.9K +216.0 (+3.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.92 -70.8% | 10 qtrs — |
| 65 | SAGEVIEW ADVISORY GROUP, LLC | 1.3K +1.3K (+100.0%) | 5.5K +5.5K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 66 | SIMPLEX TRADING, LLC | 1.0K +1.0K (+100.0%) | 4.4K +4.4K (+100.0%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 67 | FMR LLC | 903.00 -314.0 (-25.8%) | 3.9K -1.2K (-23.0%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD3.24 +34.6% | 10 qtrs — |
| 68 | PRUDENT MAN INVESTMENT MANAGEMENT, INC. | 660.00 +— (+0.0%) | 2.9K +1.3K (+84.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.36 +84.7% | 5 qtrs — |
| 69 | GROUP ONE TRADING, L.P. | 655.00 +655.0 (+100.0%) | 2.9K +2.9K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD4.36 +0.0% | 1 qtrs NEW |
| 70 | EVERSOURCE WEALTH ADVISORS, LLC | 150.00 +— (+0.0%) | 654.00 +24.0 (+3.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.20 +3.8% | 2 qtrs — |
| 71 | JPMORGAN CHASE & CO | 26.00 -2.9K (-99.1%) | 113.00 -12.3K (-99.1%) | 0.00% -0.008 pp | 0.00% +0.000 pp | USD6.58 -33.7% | 12 qtrs — |
| 72 | CITADEL ADVISORS LLC | — -20.3K (-100.0%) | — -85.3K (-100.0%) | 0.00% -0.054 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
| 73 | ROYAL BANK OF CANADA | — -6.1K (-100.0%) | — -26.0K (-100.0%) | 0.00% -0.016 pp | 0.00% +0.000 pp | USD— | 12 qtrs SOLD |
| 74 | BEACON CAPITAL MANAGEMENT, LLC | — -19.1K (-100.0%) | — -80.3K (-100.0%) | 0.00% -0.050 pp | 0.00% -0.011 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 12 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.03% | 418.3K | 0.60% |
| 2 | Vanguard Extended Market ETF VXF | 0.00% | 1.39M | 0.05% |
| 3 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 7.7K | 0.03% |
| 4 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 21.1K | 0.17% |
| 5 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 1.6K | 0.17% |
| 6 | Vanguard Total Stock Market ETF VTI | 0.00% | 3.61M | 0.03% |
| 7 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 7.9K | 0.22% |
| 8 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 4.3K | 0.22% |
| 9 | Vanguard Balanced ETF Portfolio VBAL.TO | 0.00% | 1.7K | 0.22% |
| 10 | Vanguard Conservative ETF Portfolio VCNS.TO | 0.00% | 191.86 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.17
Bearish
Ratio by volume
3.00
Bullish
Buys
1
Sells
6
Shares acquired
275.0K
Shares disposed
16.0K
Cash buys
—
Cash sales
6.00
Net activity
+259,021
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-25 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 240 | 2.51 | 602.40 | 68,073 | D | ↗ |
| 2026-03-24 | Zindrick Thomas | Officer | S-Sale | D | Common Stock | 3,582 | 2.42 | 8.7K | 534,849 | D | ↗ |
| 2026-03-24 | Yu Yong | Officer | S-Sale | D | Common Stock | 906 | 2.42 | 2.2K | 144,938 | D | ↗ |
| 2026-03-24 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 345 | 2.42 | 834.90 | 68,313 | D | ↗ |
| 2026-03-24 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 906 | 2.42 | 2.2K | 155,154 | D | ↗ |
| 2026-03-02 | Thomas John | Director | S-Sale | D | Common Stock | 10,000 | 2.90 | 29.0K | 482,784 | D | ↗ |
| 2026-01-02 | Litten Jason | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2025-12-05 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 165 | 4.69 | 773.85 | 68,658 | D | ↗ |
| 2025-12-01 | Thomas John | Director | S-Sale | D | Common Stock | 10,000 | 5.00 | 50.0K | 492,784 | D | ↗ |
| 2025-11-17 | Zindrick Thomas | Officer | S-Sale | D | Common Stock | 4,509 | 5.37 | 24.2K | 538,431 | D | ↗ |
| 2025-11-17 | Yu Yong | Officer | S-Sale | D | Common Stock | 973 | 5.37 | 5.2K | 145,844 | D | ↗ |
| 2025-11-17 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 343 | 5.37 | 1.8K | 68,823 | D | ↗ |
| 2025-11-17 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 973 | 5.37 | 5.2K | 156,060 | D | ↗ |
| 2025-09-03 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 580 | 3.36 | 1.9K | 69,166 | D | ↗ |
| 2025-09-01 | Zindrick Thomas | Director / Officer | D-Return | D | Stock Option (Right to Buy) | 250,000 | 22.40 | 5.60M | 0 | D | ↗ |
| 2025-09-01 | Yu Yong | Officer | D-Return | D | Stock Option (Right to Buy) | 207,652 | 6.00 | 1.25M | 0 | D | ↗ |
| 2025-09-01 | Smalling Ralph | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 70,990 | D | ↗ |
| 2025-09-01 | Cappello Joseph | Officer | A-Award | A | Stock Option (Right to Buy) | 80,000 | 3.33 | 266.4K | 80,000 | D | ↗ |
| 2025-08-27 | Zindrick Thomas | Officer | A-Award | A | Common Stock | 361,200 | 0.00 | — | 554,161 | D | ↗ |
| 2025-08-27 | Yu Yong | Officer | A-Award | A | Stock Option (Right to Buy) | 134,520 | 3.64 | 489.7K | 134,520 | D | ↗ |
| 2025-08-27 | Tyree James L | Director | A-Award | A | Stock Option (Right to Buy) | 28,576 | 3.64 | 104.0K | 28,576 | D | ↗ |
| 2025-08-27 | Thomas John | Director | A-Award | A | Stock Option (Right to Buy) | 28,576 | 3.64 | 104.0K | 28,576 | D | ↗ |
| 2025-08-27 | Smither John W | Director | A-Award | A | Stock Option (Right to Buy) | 28,576 | 3.64 | 104.0K | 28,576 | D | ↗ |
| 2025-08-27 | Smalling Ralph | Officer | A-Award | A | Stock Option (Right to Buy) | 34,770 | 3.64 | 126.6K | 34,770 | D | ↗ |
| 2025-08-27 | Mirabelli Mary | Director | A-Award | A | Stock Option (Right to Buy) | 28,576 | 3.64 | 104.0K | 28,576 | D | ↗ |
| 2025-08-27 | Cappello Joseph | Officer | A-Award | A | Stock Option (Right to Buy) | 142,500 | 3.64 | 518.7K | 142,500 | D | ↗ |
| 2025-08-21 | Zindrick Thomas | Officer | S-Sale | D | Common Stock | 12,673 | 3.33 | 42.2K | 542,940 | D | ↗ |
| 2025-08-21 | Yu Yong | Officer | S-Sale | D | Common Stock | 3,219 | 3.36 | 10.8K | 146,817 | D | ↗ |
| 2025-08-21 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 1,244 | 3.36 | 4.2K | 69,746 | D | ↗ |
| 2025-08-21 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 1,270 | 3.33 | 4.2K | 158,496 | D | ↗ |
| 2025-07-01 | Groen Eric | Officer | A-Award | A | Stock Option (Right to Buy) | 270,000 | 2.83 | 764.1K | 270,000 | D | ↗ |
| 2025-06-06 | Thomas John | Director | G-Gift | D | Common Stock | 25,000 | 0.00 | — | 480,501 | D | ↗ |
| 2025-05-12 | Zindrick Thomas | Director / Officer | S-Sale | D | Common Stock | 10,764 | 2.92 | 31.4K | 191,447 | D | ↗ |
| 2025-05-12 | Yu Yong | Officer | S-Sale | D | Common Stock | 5,579 | 2.92 | 16.3K | 47,640 | D | ↗ |
| 2025-05-12 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 1,259 | 2.92 | 3.7K | 34,760 | D | ↗ |
| 2025-05-12 | Ryder Sean | Officer | S-Sale | D | Common Stock | 4,475 | 2.92 | 13.1K | 47,621 | D | ↗ |
| 2025-05-12 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 4,737 | 2.92 | 13.8K | 52,266 | D | ↗ |
| 2025-03-14 | Zindrick Thomas | Director / Officer | A-Award | A | Common Stock | 30,339 | 0.00 | — | 202,211 | D | ↗ |
| 2025-03-14 | Yu Yong | Officer | A-Award | A | Common Stock | 13,350 | 0.00 | — | 53,219 | D | ↗ |
| 2025-03-14 | Smalling Ralph | Officer | A-Award | A | Common Stock | 4,172 | 0.00 | — | 36,019 | D | ↗ |
| 2025-03-14 | Ryder Sean | Officer | A-Award | A | Common Stock | 10,708 | 0.00 | — | 52,096 | D | ↗ |
| 2025-03-14 | Cappello Joseph | Officer | A-Award | A | Common Stock | 13,350 | 0.00 | — | 57,003 | D | ↗ |
| 2025-01-31 | Pulisic Matthew | Officer | A-Award | A | Stock Option (right to buy) | 275,000 | 3.95 | 1.09M | 275,000 | D | ↗ |
| 2025-01-30 | Pulisic Matthew | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-12-30 | Tyree James L | Director | S-Sale | D | Common Stock | 3,460 | 2.46 | 8.5K | 45,791 | D | ↗ |
| 2024-12-18 | Zindrick Thomas | Director / Officer | A-Award | A | Common Stock | 134,500 | 0.00 | — | 171,872 | D | ↗ |
| 2024-12-18 | Zak Lourie S. | Officer | A-Award | A | Stock Option (right to buy) | 56,525 | 2.29 | 129.4K | 56,525 | D | ↗ |
| 2024-12-18 | Yu Yong | Officer | A-Award | A | Stock Option (right to buy) | 39,000 | 2.29 | 89.3K | 39,000 | D | ↗ |
| 2024-12-18 | Smalling Ralph | Officer | A-Award | A | Common Stock | 15,525 | 0.00 | — | 31,847 | D | ↗ |
| 2024-12-18 | Ryder Sean | Officer | A-Award | A | Stock Option (right to buy) | 30,000 | 2.29 | 68.7K | 30,000 | D | ↗ |
| 2024-12-18 | Cappello Joseph | Officer | A-Award | A | Stock Option (right to buy) | 39,000 | 2.29 | 89.3K | 39,000 | D | ↗ |
| 2024-12-16 | Zindrick Thomas | Director / Officer | S-Sale | D | Common Stock | 14,315 | 2.34 | 33.5K | 37,372 | D | ↗ |
| 2024-12-16 | Zak Lourie S. | Officer | S-Sale | D | Common Stock | 2,103 | 2.34 | 4.9K | 40,802 | D | ↗ |
| 2024-12-16 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 2,510 | 2.34 | 5.9K | 16,322 | D | ↗ |
| 2024-12-16 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 6,300 | 2.34 | 14.7K | 14,653 | D | ↗ |
| 2024-10-18 | Scigalla Paul | Officer | A-Award | A | Stock Option (right to buy) | 16,666 | 6.00 | 100.0K | 16,666 | D | ↗ |
| 2024-09-13 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 33,080 | 2.57 | 84.9K | 599,821 | — | ↗ |
| 2024-09-12 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 31,777 | 2.73 | 86.7K | 632,901 | — | ↗ |
| 2024-09-11 | Tyree James L | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-09-11 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 31,376 | 2.62 | 82.2K | 664,678 | — | ↗ |
| 2024-09-10 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 20,384 | 2.51 | 51.2K | 696,054 | — | ↗ |
| 2024-09-09 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 23,383 | 2.70 | 63.2K | 716,438 | — | ↗ |
| 2024-09-03 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 42,818 | 2.09 | 89.6K | 739,821 | — | ↗ |
| 2024-08-30 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 142,589 | 2.17 | 309.8K | 782,639 | — | ↗ |
| 2024-08-29 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 107,045 | 1.98 | 212.0K | 925,228 | — | ↗ |
| 2024-08-28 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 15,918 | 2.05 | 32.6K | 1,032,273 | — | ↗ |
| 2024-08-27 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 51,630 | 2.11 | 108.9K | 1,048,191 | — | ↗ |
| 2024-08-23 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 40,000 | 2.29 | 91.4K | 1,099,821 | — | ↗ |
| 2024-08-01 | Tyree James L | Director | A-Award | A | Stock Option Right to Buy) | 50,469 | 1.96 | 98.9K | 50,469 | D | ↗ |
| 2024-08-01 | Thomas John | Director | A-Award | A | Stock Option Right to Buy) | 50,469 | 1.54 | 77.7K | 50,469 | — | ↗ |
| 2024-08-01 | Smither John W | Director | A-Award | A | Stock Option Right to Buy) | 50,469 | 1.96 | 98.9K | 50,469 | D | ↗ |
| 2024-08-01 | Mirabelli Mary | Director | A-Award | A | Common Stock | 39,541 | 0.00 | — | 52,001 | — | ↗ |
| 2024-06-24 | Yu Yong | Officer | S-Sale | D | Common Stock | 6,849 | 2.12 | 14.5K | 10,869 | — | ↗ |
| 2024-06-24 | Ryder Sean | Officer | S-Sale | D | Common Stock | 5,496 | 2.12 | 11.7K | 19,388 | — | ↗ |
| 2024-06-24 | Jewett Caroline | Officer | S-Sale | D | Common Stock | 4,961 | 2.12 | 10.5K | 16,174 | — | ↗ |
| 2024-05-29 | Zindrick Thomas | Director / Officer | P-Purchase | A | Common Stock | 200,000 | 4.00 | 800.0K | 200,000 | — | ↗ |
| 2024-05-29 | Zak Lourie S. | Officer | P-Purchase | A | Common Stock | 31,250 | 4.00 | 125.0K | 31,250 | — | ↗ |
| 2024-05-29 | Yu Yong | Officer | P-Purchase | A | Common Stock Warrant (Right to Buy) | 2,500 | 5.25 | 13.1K | 2,500 | — | ↗ |
| 2024-05-29 | Tyree James L | Director | P-Purchase | A | Common Stock Warrant (Right to Buy) | 6,250 | 5.25 | 32.8K | 6,250 | — | ↗ |
| 2024-05-29 | Thomas John | Director | P-Purchase | A | Common Stock Warrant (Right to Buy) | 2,500 | 5.25 | 13.1K | 2,500 | — | ↗ |
| 2024-05-29 | Smither John W | Director | P-Purchase | A | Common Stock Warrant (Right to Buy) | 6,250 | 5.25 | 32.8K | 6,250 | — | ↗ |
| 2024-05-29 | Smalling Ralph | Officer | P-Purchase | A | Common Stock Warrant (Right to Buy) | 1,250 | 5.25 | 6.6K | 1,250 | — | ↗ |
| 2024-05-29 | Ryder Sean | Officer | P-Purchase | A | Common Stock Warrant (Right to Buy) | 10,000 | 5.25 | 52.5K | 10,000 | — | ↗ |
| 2024-05-29 | Mirabelli Mary | Director | P-Purchase | A | Common Stock Warrant (Right to Buy) | 8,000 | 5.25 | 42.0K | 8,000 | — | ↗ |
| 2024-05-15 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 17,094 | 3.66 | 62.6K | 1,139,821 | — | ↗ |
| 2024-05-14 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 15,426 | 3.58 | 55.3K | 1,156,915 | — | ↗ |
| 2024-05-13 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 3,446 | 3.62 | 12.5K | 1,172,341 | — | ↗ |
| 2024-05-08 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 13,919 | 3.82 | 53.2K | 1,175,787 | — | ↗ |
| 2024-05-07 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 6,025 | 3.67 | 22.1K | 1,189,706 | — | ↗ |
| 2024-05-01 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 33,061 | 3.30 | 109.2K | 1,195,731 | — | ↗ |
| 2024-04-30 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 20,535 | 3.12 | 64.0K | 1,228,792 | — | ↗ |
| 2024-04-29 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 6,403 | 3.25 | 20.8K | 1,249,327 | — | ↗ |
| 2024-04-24 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 8,064 | 3.50 | 28.3K | 1,255,730 | — | ↗ |
| 2024-04-23 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 22,000 | 3.49 | 76.8K | 1,263,794 | — | ↗ |
| 2024-04-22 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 14,331 | 3.53 | 50.6K | 1,285,794 | — | ↗ |
| 2024-04-17 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 22,737 | 3.71 | 84.4K | 1,300,125 | — | ↗ |
| 2024-04-16 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 48,683 | 3.53 | 171.8K | 1,322,862 | — | ↗ |
| 2024-03-14 | Zindrick Thomas | Director / Officer | A-Award | A | Common Stock | 26,264 | 0.00 | — | 50,207 | — | ↗ |
| 2024-03-14 | Zak Lourie S. | Officer | A-Award | A | Common Stock | 3,852 | 0.00 | — | 38,428 | — | ↗ |
| 2024-03-14 | Yu Yong | Officer | A-Award | A | Common Stock | 11,557 | 0.00 | — | 17,718 | — | ↗ |
| 2024-03-14 | Smalling Ralph | Officer | A-Award | A | Common Stock | 2,107 | 0.00 | — | 18,144 | — | ↗ |
| 2024-03-14 | Ryder Sean | Officer | A-Award | A | Common Stock | 9,270 | 0.00 | — | 22,778 | — | ↗ |
| 2024-03-14 | Jewett Caroline | Officer | A-Award | A | Common Stock | 3,612 | 0.00 | — | 25,890 | — | ↗ |
| 2024-03-14 | Cappello Joseph | Officer | A-Award | A | Common Stock | 11,557 | 0.00 | — | 20,953 | — | ↗ |
| 2024-02-19 | Zindrick Thomas | Director / Officer | A-Award | A | Common Stock | 8,320 | 0.00 | — | 22,971 | — | ↗ |
| 2024-02-19 | Zak Lourie S. | Officer | A-Award | A | Common Stock | 1,220 | 0.00 | — | 32,470 | — | ↗ |
| 2024-02-19 | Yu Yong | Officer | A-Award | A | Common Stock | 3,661 | 0.00 | — | 6,161 | — | ↗ |
| 2024-02-19 | Smalling Ralph | Officer | A-Award | A | Common Stock | 616 | 0.00 | — | 13,931 | — | ↗ |
| 2024-02-19 | Ryder Sean | Officer | A-Award | A | Common Stock | 2,936 | 0.00 | — | 13,508 | — | ↗ |
| 2024-02-19 | Jewett Caroline | Officer | A-Award | A | Common Stock | 1,143 | 0.00 | — | 22,278 | — | ↗ |
| 2024-02-19 | Cappello Joseph | Officer | A-Award | A | Common Stock | 3,661 | 0.00 | — | 9,396 | — | ↗ |
| 2023-12-15 | Yu Yong | Officer | S-Sale | D | Common Stock | 26,732 | 12.94 | 345.9K | 5,803 | — | ↗ |
| 2023-12-13 | Tyree James L | Director | S-Sale | D | Common Stock | 5,653 | 12.91 | 73.0K | 6,807 | — | ↗ |
| 2023-12-13 | Thomas John | Director | S-Sale | D | Common Stock | 1,927 | 13.93 | 26.8K | 463,460 | — | ↗ |
| 2023-12-07 | Yu Yong | Officer | S-Sale | D | Common Stock | 36,800 | 11.85 | 436.0K | 32,535 | — | ↗ |
| 2023-11-21 | Yu Yong | Officer | S-Sale | D | Common Stock | 18,665 | 10.26 | 191.6K | 69,335 | — | ↗ |
| 2023-11-20 | Yu Yong | Officer | S-Sale | D | Common Stock | 14,594 | 11.26 | 164.3K | 88,000 | — | ↗ |
| 2023-11-17 | Yu Yong | Officer | S-Sale | D | Common Stock | 3,541 | 13.04 | 46.2K | 102,594 | — | ↗ |
| 2023-10-25 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 5,704 | 19.40 | 110.6K | 1,371,545 | — | ↗ |
| 2023-10-24 | Yu Yong | Officer | S-Sale | D | Common Stock | 5,200 | 19.11 | 99.4K | 106,135 | — | ↗ |
| 2023-10-23 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 49,987 | 19.97 | 998.4K | 1,377,249 | — | ↗ |
| 2023-10-16 | Thomas John | Director | S-Sale | D | Common Stock | 881 | 21.30 | 18.8K | 472,460 | — | ↗ |
| 2023-10-10 | Yu Yong | Officer | S-Sale | D | Common Stock | 4,800 | 21.94 | 105.3K | 106,535 | — | ↗ |
| 2023-10-05 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 13,266 | 24.89 | 330.1K | 1,428,221 | — | ↗ |
| 2023-10-03 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 75,690 | 25.49 | 1.93M | 1,441,487 | — | ↗ |
| 2023-10-02 | Jewett Caroline | Officer | A-Award | A | Stock Option (right to buy) | 22,000 | 24.75 | 544.5K | 22,000 | — | ↗ |
| 2023-09-28 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 2,289 | 24.12 | 55.2K | 1,517,177 | — | ↗ |
| 2023-09-27 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 11,257 | 24.47 | 275.5K | 1,519,466 | — | ↗ |
| 2023-09-26 | Yu Yong | Officer | M-Exempt | A | Common Stock | 5,200 | 6.00 | 31.2K | 111,335 | — | ↗ |
| 2023-09-26 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 12,740 | 24.03 | 306.1K | 1,540,323 | — | ↗ |
| 2023-09-25 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 3,947 | 24.82 | 98.0K | 1,569,039 | — | ↗ |
| 2023-09-22 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 4,421 | 26.88 | 118.9K | 1,577,607 | — | ↗ |
| 2023-09-21 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 2,871 | 27.89 | 80.1K | 1,586,706 | — | ↗ |
| 2023-09-20 | Yu Yong | Officer | M-Exempt | D | Stock Option (right to buy) | 6,000 | 6.00 | 36.0K | 223,253 | — | ↗ |
| 2023-09-20 | Ryder Sean | Officer | M-Exempt | D | Stock Option (right to buy) | 10,000 | 6.00 | 60.0K | 140,000 | — | ↗ |
| 2023-09-19 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 23,920 | 26.21 | 627.0K | 8,247 | — | ↗ |
| 2023-09-18 | Thomas John | Director | S-Sale | D | Common Stock | 3,334 | 24.99 | 83.3K | 475,793 | — | ↗ |
| 2023-09-18 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 2,927 | 24.17 | 70.8K | 5,000 | — | ↗ |
| 2023-09-15 | Yu Yong | Officer | M-Exempt | A | Common Stock | 10,400 | 6.00 | 62.4K | 116,535 | — | ↗ |
| 2023-09-15 | Thomas John | Director | S-Sale | D | Common Stock | 2,245 | 21.67 | 48.6K | 480,215 | — | ↗ |
| 2023-09-14 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 13,871 | 22.31 | 309.5K | 35,292 | — | ↗ |
| 2023-09-13 | Yu Yong | Officer | S-Sale | D | Common Stock | 29,800 | 21.14 | 629.9K | 106,135 | — | ↗ |
| 2023-09-13 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 15,717 | 21.26 | 334.1K | 63,883 | — | ↗ |
| 2023-09-13 | Smither John W | Director | S-Sale | D | Common Stock | 900 | 20.78 | 18.7K | 6,920 | — | ↗ |
| 2023-09-12 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 13,727 | 22.51 | 308.9K | 79,600 | — | ↗ |
| 2023-09-11 | Zindrick Thomas | Director / Officer | A-Award | A | Stock Option (right to buy) | 250,000 | 22.40 | 5.60M | 250,000 | — | ↗ |
| 2023-09-11 | Zak Lourie S. | Officer | A-Award | A | Stock Option (right to buy) | 150,000 | 22.40 | 3.36M | 150,000 | — | ↗ |
| 2023-09-11 | Yu Yong | Officer | A-Award | A | Stock Option (right to buy) | 65,000 | 22.40 | 1.46M | 65,000 | — | ↗ |
| 2023-09-11 | Tyree James L | Director | A-Award | A | Stock Option (Right to Buy) | 4,397 | 22.40 | 98.5K | 4,397 | — | ↗ |
| 2023-09-11 | Thomas John | Director | A-Award | A | Common Stock | 3,460 | 0.00 | — | 482,460 | — | ↗ |
| 2023-09-11 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 23,020 | 22.55 | 519.2K | 99,865 | — | ↗ |
| 2023-09-11 | Smither John W | Director | — | D | Common Stock | 0 | 0.00 | — | 900 | — | ↗ |
| 2023-09-11 | Smalling Ralph | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 12,065 | — | ↗ |
| 2023-09-11 | Samuelson Doug | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 22.40 | 896.0K | 40,000 | — | ↗ |
| 2023-09-11 | Ryder Sean | Officer | A-Award | A | Stock Option (right to buy) | 40,000 | 22.40 | 896.0K | 40,000 | — | ↗ |
| 2023-09-11 | Mirabelli Mary | Director | A-Award | A | Common Stock | 3,460 | 0.00 | — | 4,460 | — | ↗ |
| 2023-09-11 | Jewett Caroline | Officer | A-Award | A | Common Stock | 20,000 | 0.00 | — | 21,135 | — | ↗ |
| 2023-09-11 | Cappello Joseph | Officer | A-Award | A | Stock Option (right to buy) | 65,000 | 22.40 | 1.46M | 65,000 | — | ↗ |
| 2023-09-08 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 13,672 | 22.78 | 311.4K | 143,375 | — | ↗ |
| 2023-09-07 | Szalay Aladar | 10% Owner | S-Sale | D | Common Stock | 9,938 | 24.12 | 239.7K | 159,555 | — | ↗ |
| 2023-08-30 | Yu Yong | Officer | S-Sale | D | Common Stock | 19,800 | 24.70 | 489.1K | 135,935 | — | ↗ |
| 2023-08-28 | Zak Lourie S. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-18 | Zindrick Thomas | Director / Officer | S-Sale | D | Common Stock | 8,349 | 23.73 | 198.1K | 14,651 | — | ↗ |
| 2023-08-18 | Yu Yong | Officer | S-Sale | D | Common Stock | 3,265 | 23.73 | 77.5K | 155,735 | — | ↗ |
| 2023-08-18 | Smalling Ralph | Officer | S-Sale | D | Common Stock | 935 | 23.73 | 22.2K | 2,065 | — | ↗ |
| 2023-08-18 | Samuelson Doug | Officer | S-Sale | D | Common Stock | 1,297 | 23.73 | 30.8K | 2,303 | — | ↗ |
| 2023-08-18 | Ryder Sean | Officer | S-Sale | D | Common Stock | 328 | 23.73 | 7.8K | 572 | — | ↗ |
| 2023-08-18 | Jewett Caroline | Officer | S-Sale | D | Common Stock | 515 | 23.73 | 12.2K | 1,135 | — | ↗ |
| 2023-08-18 | Cappello Joseph | Officer | S-Sale | D | Common Stock | 3,265 | 23.73 | 77.5K | 5,735 | — | ↗ |
| 2023-06-30 | Smalling Ralph | Officer | — | D | Common Stock | 0 | 0.00 | — | 3,000 | — | ↗ |
| 2023-06-30 | Jewett Caroline | Officer | — | D | Common Stock | 0 | 0.00 | — | 1,650 | — | ↗ |
| 2023-02-27 | Zindrick Thomas | Director / Officer | A-Award | A | Common Stock | 23,000 | 0.00 | — | 23,000 | — | ↗ |
| 2023-02-17 | Zhang Qian | Officer | A-Award | A | Common Stock | 6,000 | 0.00 | — | 139,333 | — | ↗ |
| 2023-02-17 | Yu Tony | Officer | A-Award | A | Common Stock | 9,000 | 0.00 | — | 159,000 | — | ↗ |
| 2023-02-17 | Woodward Gabe | Director | A-Award | A | Common Stock | 1,000 | 0.00 | — | 4,186 | — | ↗ |
| 2023-02-17 | Tyree James L | Director | A-Award | A | Common Stock | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2023-02-17 | Thomas John | Director | A-Award | A | Common Stock | 9,000 | 0.00 | — | 479,000 | — | ↗ |
| 2023-02-17 | Samuelson Doug | Officer | A-Award | A | Common Stock | 3,600 | 0.00 | — | 3,600 | — | ↗ |
| 2023-02-17 | Ryder Sean | Officer | A-Award | A | Common Stock | 900 | 0.00 | — | 900 | — | ↗ |
| 2023-02-17 | Mirabelli Mary | Director | A-Award | A | Common Stock | 1,000 | 0.00 | — | 1,000 | — | ↗ |
| 2023-02-17 | Cappello Joseph | Officer | A-Award | A | Common Stock | 9,000 | 0.00 | — | 9,000 | — | ↗ |
| 2023-01-30 | Woodward Gabe | Director | C-Conversion | A | Common Stock | 2,798 | 0.00 | — | 2,798 | — | ↗ |
| 2023-01-30 | Thomas John | Director | C-Conversion | A | Common Stock | 470,000 | 0.00 | — | 470,000 | — | ↗ |
| 2023-01-30 | Szalay Aladar | Director | C-Conversion | D | Series A Preferred Stock | 1,500,000 | 0.00 | — | 0 | — | ↗ |
| 2023-01-26 | Zhang Qian | Officer | P-Purchase | A | Common Stock | 200 | 6.25 | 1.2K | 200 | — | ↗ |
| 2023-01-25 | Zindrick Thomas | Officer | — | D | Stock Option (right to buy) | 23,568 | 10.50 | 247.5K | — | — | ↗ |
| 2023-01-25 | Zhang Qian | Officer | — | D | Stock Option (right to buy) | 239,653 | 10.50 | 2.52M | — | — | ↗ |
| 2023-01-25 | Yu Tony | Officer | — | D | Common Stock | 0 | 0.00 | — | 150,000 | — | ↗ |
| 2023-01-25 | Woodward Gabe | Director | — | D | Stock Option (right to buy) | 25,000 | 10.50 | 262.5K | — | — | ↗ |
| 2023-01-25 | Tyree James L | Director | — | D | Stock Option (right to buy) | 25,000 | 10.50 | 262.5K | — | — | ↗ |
| 2023-01-25 | Thomas John | Director | — | D | Stock Option (right to buy) | 25,000 | 10.50 | 262.5K | — | — | ↗ |
| 2023-01-25 | Szalay Aladar | Director | — | D | Common Stock | 0 | 0.00 | — | 32,167 | — | ↗ |
| 2023-01-25 | Scigalla Paul | Officer | — | D | Stock Option (right to buy) | 16,666 | 9.00 | 150.0K | — | — | ↗ |
| 2023-01-25 | Samuelson Doug | Officer | — | D | Stock Option (right to buy) | 88,300 | 10.50 | 927.2K | — | — | ↗ |
| 2023-01-25 | Ryder Sean | Officer | — | D | Stock Option (right to buy) | 150,000 | 10.50 | 1.58M | — | — | ↗ |
| 2023-01-25 | Mirabelli Mary | Director | — | D | Stock Option (right to buy) | 25,000 | 10.50 | 262.5K | — | — | ↗ |
| 2023-01-25 | Cappello Joseph | Officer | — | D | Stock Option (right to buy) | 13,333 | 10.50 | 140.0K | — | — | ↗ |
Executive team
Top executives
EBIT / Employee
-13.8K
Shares Outstanding
37.62M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Thomas D. Zindrick, J.D. President and Chief Executive Officer | 613.0K | — | 1.42M | 2.07M | 168.1K | 3.0K | 4.28M | 81.67% | ↗ |
| 2 | 2025 | Matthew Pulisic Chief Financial Officer | 406.7K | — | — | 997.5K | 82.6K | 220.00 | 1.49M | 67.08% | ↗ |
| 3 | 2025 | Joseph Cappello, Ph.D. Chief Technical Officer | 390.0K | — | 437.6K | 533.6K | 77.8K | 3.0K | 1.44M | 67.35% | ↗ |
| 4 | 2024 | Thomas D. Zindrick, J.D. President and Chief Executive Officer | 595.0K | — | 536.9K | 338.3K | 105.1K | 3.0K | 1.58M | 55.45% | ↗ |
| 5 | 2024 | Joseph Cappello, Ph.D. Chief Technical Officer | 360.0K | — | 166.7K | 72.1K | 46.3K | 3.0K | 648.1K | 36.84% | ↗ |
| 6 | 2024 | Lourie Zak Former Chief Financial Officer | 360.0K | — | 129.0K | 104.5K | — | 1.6K | 595.0K | 39.23% | ↗ |
| 7 | 2023 | Thomas Zindrick, J.D. President and Chief Executive Officer | 570.5K | — | 151.1K | 5.48M | — | 471.00 | 6.20M | 90.79% | ↗ |
| 8 | 2023 | Thomas D. Zindrick, J.D. President and Chief Executive Officer | 570.5K | — | 151.1K | 5.48M | — | 471.00 | 6.20M | 90.79% | ↗ |
| 9 | 2023 | Lourie Zak Former Chief Financial Officer | 119.1K | — | — | 2.71M | — | 157.00 | 2.83M | 95.79% | ↗ |
| 10 | 2023 | Lourie Zak Chief Financial Officer | 119.1K | — | — | 2.71M | — | 157.00 | 2.83M | 95.79% | ↗ |
| 11 | 2023 | Caroline Jewett Vice President, Head of Quality | 134.5K | — | — | 2.03M | — | 188.00 | 2.62M | 77.47% | ↗ |
| 12 | 2022 | Doug Samuelson Chief Financial Officer | 85.1K | — | — | 822.4K | — | 165.3K | 1.07M | 76.66% | ↗ |
| 13 | 2022 | Thomas Zindrick, J.D. President and Chief Executive Officer | 500.0K | — | — | — | — | — | 516.9K | 0.00% | ↗ |
| 14 | 2022 | Sean Ryder, J.D. General Counsel and Corporate Secretary | 330.0K | 50.0K | — | — | — | — | 380.0K | 0.00% | ↗ |
| 15 | 2021 | Sean Ryder, J.D. General Counsel and Corporate Secretary | 80.0K | 50.0K | — | 1.21M | — | — | 1.34M | 90.29% | ↗ |
| 16 | 2021 | Thomas Zindrick, J.D. President and Chief Executive Officer | 500.0K | — | — | — | — | 16.9K | 516.9K | 0.00% | ↗ |
| 17 | 2021 | Doug Samuelson Chief Financial Officer | — | — | — | — | — | 240.0K | 240.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Thomas Zindrick | Chairman, Chief Executive Officer & President | 784.2K | male |
| Joseph Cappello | Chief Technical Officer | 363.0K | — |
| Yong Yu | Senior Vice President of Clinical Development | 242.6K | — |
| Ralph Smalling | Vice President & Head of Regulatory Affairs | — | male |
| Matthew Pulisic | Chief Financial Officer and Principal Financial & Accounting Officer | — | male |
| Jason Litten | Chief Medical Officer | — | — |
| Eric Groen | General Counsel, Corporate Secretary, Chief Compliance Officer & Head of Business Development | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GNLX
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
